Instylla, Inc., a developer of resorbable embolics for peripheral vascular embolization, announced that the FDA has approved an ...

Siemens Healthineers announced the strategic focus of its ultrasound business is shifting to procedural imaging and image-guide ...

AdvaMed, the Advanced Medical Technical Association, announced it recommended refinements to the Centers for Medicare & Med ...

The United Kingdom’s Medicines and Healthcare Agency (MHRA) announced that the government confirmed it will continue to a ...

IceCure Medical Ltd., developer of minimally invasive cryoablation technology, announced the enrollment of the first two ...

Jupiter Endovascular, Inc. announced that the full results of the SPIRARE II pivotal trial, evaluating the company’s Vert ...

A summary of four recent studies evaluating locoregional therapies for hepatocellular carcinoma and percutaneous ablation for ...

The ELEGANCE registry, which focuses on historically underrepresented populations to generate real-world evidence, evaluated en ...

A study of computer-assisted vacuum thrombectomy (CAVT) met its predefined primary effectiveness and safety endpoints for the t ...

Penumbra, Inc. announced that the FDA has granted clearance for the treatment of deep vein thrombosis (DVT) to the company&rsqu ...

Six-month results from Esprit BTK PAS were reported in patients with chronic limb-threatening ischemia (CLTI) treated with the ...

One-year results from the prospective, multicenter, single-arm PROMISE III trial evaluated transcatheter arterialization of the ...